On June 19th, Gelonhui announced that on June 19, 2024 the trustee had purchased a total of 5 million shares of company stock in the market as part of the stock incentive plan, with an average cost of approximately HKD 0.5918 per share.
四环医药(00460.HK)：受托人就股份奖励计划购买合共500万股
Sihuan Pharm (00460.HK): The trustee purchased a total of 5 million shares as part of the stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.